169 related articles for article (PubMed ID: 37523991)
1. Ibrutinib and tracheal mucormycosis: A case report and systematic review of literature.
Damaraju V; Agarwal R; Singh Sehgal I; Khadwal A; Bal A; Rudramurthy SM; Muthu V
J Mycol Med; 2023 Aug; 33(3):101414. PubMed ID: 37523991
[TBL] [Abstract][Full Text] [Related]
2. Isolated tracheobronchial mucormycosis: Report of a case and systematic review of literature.
Damaraju V; Agarwal R; Dhooria S; Sehgal IS; Prasad KT; Gupta K; Prabhakar N; Aggarwal AN; Muthu V
Mycoses; 2023 Jan; 66(1):5-12. PubMed ID: 35984683
[TBL] [Abstract][Full Text] [Related]
3. [Clinical analysis of 3 cases of mucormycosis in children with acute lymphoblastic leukemia and literature review].
Sun HY; Li B; Liu Y; You HL; Liu YF
Zhonghua Er Ke Za Zhi; 2022 Jan; 60(1):56-61. PubMed ID: 34986625
[No Abstract] [Full Text] [Related]
4. Tracheal mucormycosis pneumonia: a rare clinical presentation.
Mohindra S; Gupta B; Gupta K; Bal A
Respir Care; 2014 Nov; 59(11):e178-81. PubMed ID: 25006272
[TBL] [Abstract][Full Text] [Related]
5. Ibrutinib-associated sever skin toxicity: A case of multiple inflamed skin lesions and cellulitis in a 68-year-old male patient with relapsed chronic lymphocytic leukemia - Case report and literature review.
Ghasoub R; Albattah A; Elazzazy S; Alokka R; Nemir A; Alhijji I; Taha R
J Oncol Pharm Pract; 2020 Mar; 26(2):487-491. PubMed ID: 31216242
[TBL] [Abstract][Full Text] [Related]
6. Periorbital zygomycosis (mucormycosis) treated with posaconazole.
Rutar T; Cockerham KP
Am J Ophthalmol; 2006 Jul; 142(1):187-188. PubMed ID: 16815283
[TBL] [Abstract][Full Text] [Related]
7. Cutaneous mucormycosis in a chronic lymphocytic leukemia patient on ibrutinib.
Sittig KR; Laageide LG; Akhtar Z; Wall GC; Kumar SC
IDCases; 2021; 24():e01120. PubMed ID: 33912391
[TBL] [Abstract][Full Text] [Related]
8. Zanubrutinib in patients with previously treated B-cell malignancies intolerant of previous Bruton tyrosine kinase inhibitors in the USA: a phase 2, open-label, single-arm study.
Shadman M; Flinn IW; Levy MY; Porter RF; Burke JM; Zafar SF; Misleh J; Kingsley EC; Yimer HA; Freeman B; Rao SS; Chaudhry A; Tumula PK; Gandhi MD; Manda S; Chen DY; By K; Xu L; Liu Y; Crescenzo R; Idoine A; Zhang X; Cohen A; Huang J; Sharman JP
Lancet Haematol; 2023 Jan; 10(1):e35-e45. PubMed ID: 36400069
[TBL] [Abstract][Full Text] [Related]
9. Cutaneous mucormycosis.
Vulsteke JB; Deeren D
Transpl Infect Dis; 2019 Apr; 21(2):e13039. PubMed ID: 30548761
[TBL] [Abstract][Full Text] [Related]
10. Inflammatory pseudotumoural endotracheal mucormycosis with cartilage damage.
Luo LC; Cheng DY; Zhu H; Shu X; Chen WB
Eur Respir Rev; 2009 Sep; 18(113):186-9. PubMed ID: 20956142
[TBL] [Abstract][Full Text] [Related]
11. Diffuse Alveolar Hemorrhage Secondary to Ibrutinib Therapy in a Patient With Refractory Mantle Cell Lymphoma.
Locke CB; Lansigan F
Cureus; 2020 Jun; 12(6):e8743. PubMed ID: 32714681
[TBL] [Abstract][Full Text] [Related]
12. Eradication of invasive mucormycosis--effectiveness of the Echinocandin FK463.
Jacobs P; Wood L; Du Toit A; Esterhuizen K
Hematology; 2003 Apr; 8(2):119-23. PubMed ID: 12745662
[TBL] [Abstract][Full Text] [Related]
13. Bruton tyrosine kinase inhibitor ibrutinib (PCI-32765) has significant activity in patients with relapsed/refractory B-cell malignancies.
Advani RH; Buggy JJ; Sharman JP; Smith SM; Boyd TE; Grant B; Kolibaba KS; Furman RR; Rodriguez S; Chang BY; Sukbuntherng J; Izumi R; Hamdy A; Hedrick E; Fowler NH
J Clin Oncol; 2013 Jan; 31(1):88-94. PubMed ID: 23045577
[TBL] [Abstract][Full Text] [Related]
14. [Pulmonary mucormycosis: report of 5 cases and review of 46 cases reported in China].
Yang YM; Fang BM; Xu XM; Fang F; Pan MM; Zhong XF; Sun TY
Zhonghua Jie He He Hu Xi Za Zhi; 2013 Aug; 36(8):572-6. PubMed ID: 24252732
[TBL] [Abstract][Full Text] [Related]
15. Ibrutinib-associated cutaneous mucormycosis due to an
Nguyen TM; Amenta E; Chapman L; Yellapragada S; Krishnan B; Lim J; Hamill RJ
Ther Adv Infect Dis; 2024; 11():20499361241241199. PubMed ID: 38545450
[TBL] [Abstract][Full Text] [Related]
16. Report of 12 cases with tracheobronchial mucormycosis and a review.
He R; Hu C; Tang Y; Yang H; Cao L; Niu R
Clin Respir J; 2018 Apr; 12(4):1651-1660. PubMed ID: 29028140
[TBL] [Abstract][Full Text] [Related]
17. Successful management of hepatic mucormycosis in an acute lymphoblastic leukaemia patient: a case report and review of the literature.
Tuysuz G; Ozdemir N; Senyuz OF; Emre S; Kantarcioglu S; Adaletli I; Kepil N; Tutuncu C; Celkan T
Mycoses; 2014 Aug; 57(8):513-8. PubMed ID: 24635874
[TBL] [Abstract][Full Text] [Related]
18. [Invasive zygomycosis in patients treated for haematological malignancies].
Verweij PE; van der Velden WJ; Donnelly JP; Blijlevens NM; Warris A
Ned Tijdschr Geneeskd; 2007 Nov; 151(47):2597-602. PubMed ID: 18161258
[TBL] [Abstract][Full Text] [Related]
19. Ibrutinib-associated tumor lysis syndrome in chronic lymphocytic leukemia/small lymphocytic lymphoma and mantle cell lymphoma: A case series and review of the literature.
Titus-Rains KS; Brown JN; Hammond JM
J Oncol Pharm Pract; 2018 Oct; 24(7):544-549. PubMed ID: 28714377
[TBL] [Abstract][Full Text] [Related]
20. Severe pneumonia associated with ibrutinib monotherapy for CLL and lymphoma.
Kreiniz N; Bejar J; Polliack A; Tadmor T
Hematol Oncol; 2018 Feb; 36(1):349-354. PubMed ID: 28156016
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
